Real-time enrollment status for this pancreas adenocarcinoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 8:51 AM UTC
| NCT Number | NCT05825066 |
| Recruiting Status | Recruiting |
| Condition | Pancreas Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 64 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Wake Forest University Health Sciences |
| Last Updated on CT.gov | August 11, 2026 (3 weeks ago) |
As of September 1, 2026: Clinical trial NCT05825066 is currently recruiting participants. This phase2 study for pancreas adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Wake Forest University Health Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05825066 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05825066 was last updated 3 weeks ago (August 11, 2026). HelloStudys verifies this status automatically.